Pfizer
Ebonie Sampson is an accomplished professional in clinical operations with extensive experience in the pharmaceutical industry. Currently serving as the Clinical Study Team Lead- Director at Pfizer since April 2022, Ebonie previously held the position of Senior Consultant at Halloran Consulting Group, Inc. from March 2020 to April 2022. Prior to that, Ebonie worked as Project Director ECD in Oncology at Covance from May 2017 to April 2020 and as Clinical Trial Manager at Pharmacyclics from November 2015 to May 2017. Ebonie's career includes a role as Sr. Manager of Clinical Operations at Radius Health, Inc. from April 2015 to October 2015. Ebonie holds a Master of Science in Clinical Investigation from MGH Institute of Health Professions and a Bachelor of Science in Biotechnology from Rutgers University.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.